Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) was the recipient of a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 23,530,000 shares,  a decrease of 6.0% from the November 15th total of 25,020,000 shares. Based on an average daily volume of 1,990,000 shares, the short-interest ratio is currently 11.8 days.

marketbeat.com

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Sees Large Drop in Short Interest

Media Bias/Fact Check

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 23,530,000 shares, a decline of 6.0% from the November 15th total of 25,020,000 shares. Based on an average trading volume of 1,990,000 shares, […]

reporter.am

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 120,900 shares,  an increase of 19.2% from the November 15th total of 101,400 shares. Based on an average trading volume of 143,400 shares, the short-interest ratio is currently 0.8 days. Currently, 0.5% of the company’s shares are short sold.  Analyst Ratings Chan…

modernreaders.com

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Large Growth in Short Interest

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) was the recipient of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 23,530,000 shares, a drop of 6.0% from the November 15th total of 25,020,000 shares. Based on an average trading volume of 1,990,000 shares, […]

watchlistnews.com

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Short Interest Update

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) saw a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 120,900 shares, a growth of 19.2% from the November 15th total of 101,400 shares. Approximately 0.5% of the company’s shares are short sold. Based on an […]

com-unik.info

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) was the target of a significant decline in short interest in November. As of November 30th, there was short interest totalling 23,530,000 shares, a decline of 6.0% from the November 15th total of 25,020,000 shares. Based on an average daily trading volume, of 1,990,000 shares, the days-to-cover […]

americanbankingnews.com

Short Interest in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Decreases By 6.0%

The supplemental New Drug Application is supported by positive results from the INTEGUMENT-PED and INTEGUMENT-OLE trials.

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Sees Large Drop in Short Interest

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics